HYDROXYZINE HYDROCHLORIDE ORAL

HYDROXYZINE HYDROCHLORIDE ORAL was reported 13792 times

These side effects are most commonly reported by patients taking HYDROXYZINE HYDROCHLORIDE ORAL:

# Side effect Count
0 PRURITUS 1155
1 DRUG INEFFECTIVE 1033
2 NAUSEA 877
3 FATIGUE 862
4 RASH 832
5 HEADACHE 824
6 PRODUCT DOSE OMISSION ISSUE 807
7 PAIN 744
8 OFF LABEL USE 698
9 TOXICITY TO VARIOUS AGENTS 638
10 DIARRHOEA 636
11 DYSPNOEA 597
12 VOMITING 554
13 DERMATITIS ATOPIC 539
14 DIZZINESS 507
15 PRODUCT USE IN UNAPPROVED INDICATION 474
16 ARTHRALGIA 438
17 COMPLETED SUICIDE 425
18 ANXIETY 422
19 COUGH 412
20 PYREXIA 412
21 MALAISE 411
22 FALL 410
23 INJECTION SITE PAIN 407
24 PNEUMONIA 386
25 DRY SKIN 374
26 CONDITION AGGRAVATED 358
27 URTICARIA 351
28 COVID-19 349
29 ASTHENIA 317
30 WEIGHT DECREASED 311
31 ILLNESS 309
32 INSOMNIA 305
33 DEATH 299
34 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 299
35 SOMNOLENCE 292
36 BACK PAIN 286
37 PAIN IN EXTREMITY 285
38 ASTHMA 282
39 DEPRESSION 279
40 URINARY TRACT INFECTION 276
41 HYPOTENSION 272
42 SLEEP DISORDER 265
43 NASOPHARYNGITIS 260
44 DRUG ABUSE 259
45 DISCOMFORT 257
46 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 255
47 ECZEMA 252
48 ERYTHEMA 251
49 SINUSITIS 250
50 CONSTIPATION 242
51 SKIN EXFOLIATION 241
52 DECREASED APPETITE 240
53 INFECTION 237
54 WEIGHT INCREASED 231
55 ABDOMINAL PAIN 230
56 FEELING ABNORMAL 230
57 HYPERTENSION 226
58 HYPERSENSITIVITY 221
59 CHEST PAIN 218
60 PERIPHERAL SWELLING 217
61 ABDOMINAL PAIN UPPER 211
62 PRODUCT USE ISSUE 211
63 ACUTE KIDNEY INJURY 198
64 ABDOMINAL DISCOMFORT 197
65 INFLUENZA 197
66 CHRONIC KIDNEY DISEASE 182
67 TREMOR 181
68 BLOOD PRESSURE INCREASED 179
69 MIGRAINE 174
70 DRUG HYPERSENSITIVITY 165
71 MUSCLE SPASMS 162
72 DRUG INTERACTION 160
73 ANAEMIA 157
74 BRONCHITIS 150
75 CARDIO-RESPIRATORY ARREST 150
76 MYALGIA 149
77 ALOPECIA 148
78 RENAL FAILURE 144
79 GAIT DISTURBANCE 143
80 HOSPITALISATION 143
81 MEMORY IMPAIRMENT 143
82 INCORRECT DOSE ADMINISTERED 142
83 SEPSIS 141
84 DEHYDRATION 140
85 VISION BLURRED 140
86 GASTROOESOPHAGEAL REFLUX DISEASE 137
87 OVERDOSE 136
88 CONFUSIONAL STATE 133
89 HYPERHIDROSIS 133
90 PSORIASIS 133
91 EYE PAIN 129
92 SKIN FISSURES 128
93 HYPOAESTHESIA 127
94 SUICIDAL IDEATION 126
95 SWELLING 126
96 HEART RATE INCREASED 123
97 OROPHARYNGEAL PAIN 123
98 THERAPY INTERRUPTED 123
99 CHEST DISCOMFORT 122
100 INFUSION SITE PAIN 121
101 UPPER RESPIRATORY TRACT INFECTION 121
102 PRODUCT DOSE OMISSION IN ERROR 120
103 THERAPEUTIC RESPONSE DECREASED 120
104 DRY EYE 117
105 SURGERY 117
106 TACHYCARDIA 117
107 PALPITATIONS 116
108 SEIZURE 116
109 GASTROINTESTINAL DISORDER 115
110 INTENTIONAL OVERDOSE 114
111 STRESS 114
112 CHILLS 113
113 EYE IRRITATION 113
114 PARAESTHESIA 113
115 THERAPEUTIC RESPONSE SHORTENED 113
116 MUSCULAR WEAKNESS 111
117 RASH PRURITIC 111
118 SYNCOPE 110
119 INTENTIONAL PRODUCT USE ISSUE 109
120 OXYGEN SATURATION DECREASED 109
121 LOSS OF CONSCIOUSNESS 108
122 OCULAR HYPERAEMIA 108
123 CONTUSION 105
124 RHINORRHOEA 103
125 IMPAIRED QUALITY OF LIFE 101
126 DYSPEPSIA 100
127 DYSPHAGIA 99
128 OEDEMA PERIPHERAL 99
129 COMA 98
130 VISUAL IMPAIRMENT 98
131 INJECTION SITE SWELLING 95
132 NASAL CONGESTION 95
133 ABDOMINAL DISTENSION 94
134 EYE PRURITUS 93
135 MYOCARDIAL INFARCTION 93
136 DRY MOUTH 90
137 EAR INFECTION 90
138 PRODUCTIVE COUGH 90
139 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 90
140 DERMATITIS CONTACT 89
141 INJECTION SITE BRUISING 89
142 DRUG INTOLERANCE 88
143 INTENTIONAL PRODUCT MISUSE 88
144 PLATELET COUNT DECREASED 88
145 BLOOD PRESSURE DECREASED 87
146 FLUSHING 86
147 SEASONAL ALLERGY 86
148 CARDIAC ARREST 85
149 BALANCE DISORDER 84
150 PRODUCT ADMINISTRATION INTERRUPTED 84
151 VERTIGO 84
152 BURNING SENSATION 83
153 OEDEMA 82
154 OSTEOPOROSIS 81
155 HYPONATRAEMIA 80
156 ACCIDENTAL EXPOSURE TO PRODUCT 79
157 AMNESIA 79
158 SUICIDE ATTEMPT 79
159 WHITE BLOOD CELL COUNT DECREASED 79
160 AGITATION 78
161 CEREBROVASCULAR ACCIDENT 77
162 EMOTIONAL DISTRESS 77
163 INJECTION SITE REACTION 77
164 INJECTION SITE ERYTHEMA 76
165 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 76
166 BLISTER 75
167 HALLUCINATION 75
168 MOBILITY DECREASED 75
169 DYSPHONIA 74
170 HOT FLUSH 74
171 INSURANCE ISSUE 74
172 INTENTIONAL DOSE OMISSION 74
173 NEUROPATHY PERIPHERAL 74
174 SKIN HAEMORRHAGE 74
175 THROMBOSIS 73
176 ARTHRITIS 72
177 ELECTROCARDIOGRAM QT PROLONGED 72
178 INFUSION SITE ERYTHEMA 72
179 CARDIAC DISORDER 71
180 THERAPY NON-RESPONDER 71
181 RESPIRATORY TRACT INFECTION 70
182 THROMBOCYTOPENIA 70
183 HERPES ZOSTER 69
184 JOINT SWELLING 69
185 RASH MACULAR 69
186 NECK PAIN 68
187 DYSPNOEA EXERTIONAL 67
188 FEELING HOT 67
189 INJECTION SITE PRURITUS 67
190 SCRATCH 67
191 WHEEZING 67
192 EPISTAXIS 66
193 NEPHROLITHIASIS 66
194 SKIN BURNING SENSATION 66
195 ATRIAL FIBRILLATION 65
196 EXPOSURE VIA SKIN CONTACT 64
197 MUSCULOSKELETAL STIFFNESS 63
198 ANAPHYLACTIC REACTION 62
199 INFLUENZA LIKE ILLNESS 62
200 INFUSION RELATED REACTION 62
201 SKIN DISCOLOURATION 62
202 STOMATITIS 62
203 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 62
204 DERMATITIS 61
205 FLUID RETENTION 61
206 VIRAL INFECTION 61
207 BLOOD GLUCOSE INCREASED 60
208 BONE PAIN 60
209 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60
210 MENTAL DISORDER 60
211 THROAT IRRITATION 60
212 COGNITIVE DISORDER 59
213 DRUG DEPENDENCE 59
214 PANIC ATTACK 59
215 TINNITUS 59
216 CATARACT 58
217 DIABETES MELLITUS 58
218 INFUSION SITE DISCHARGE 58
219 NO ADVERSE EVENT 58
220 PAIN IN JAW 58
221 TREATMENT NONCOMPLIANCE 58
222 URINARY RETENTION 58
223 ADVERSE DRUG REACTION 57
224 CARDIAC FAILURE 57
225 CELLULITIS 57
226 GENERAL PHYSICAL HEALTH DETERIORATION 57
227 HAEMORRHAGE 57
228 NEUTROPENIA 57
229 UNEVALUABLE EVENT 57
230 HYPOXIA 56
231 ORAL HERPES 56
232 RASH ERYTHEMATOUS 55
233 DYSURIA 54
234 EYE SWELLING 54
235 PSORIATIC ARTHROPATHY 54
236 RASH MACULO-PAPULAR 54
237 RHEUMATOID ARTHRITIS 54
238 SWELLING FACE 54
239 ALANINE AMINOTRANSFERASE INCREASED 53
240 DISTURBANCE IN ATTENTION 53
241 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53
242 HAEMOGLOBIN DECREASED 53
243 HYPOKALAEMIA 53
244 DEEP VEIN THROMBOSIS 52
245 RESPIRATORY FAILURE 52
246 ANHEDONIA 51
247 ASPARTATE AMINOTRANSFERASE INCREASED 51
248 HYPERSOMNIA 51
249 MULTIPLE ALLERGIES 51
250 EOSINOPHILIA 50
251 SEROTONIN SYNDROME 50
252 SKIN IRRITATION 50
253 ANGIOEDEMA 49
254 FUNGAL INFECTION 49
255 HEPATIC CYTOLYSIS 49
256 LOCALISED INFECTION 49
257 MEDICATION ERROR 49
258 CYSTITIS 48
259 DEPRESSED MOOD 48
260 ILL-DEFINED DISORDER 48
261 INFUSION SITE HAEMORRHAGE 48
262 LACRIMATION INCREASED 48
263 LUNG DISORDER 48
264 RENAL IMPAIRMENT 48
265 ROAD TRAFFIC ACCIDENT 48
266 STAPHYLOCOCCAL INFECTION 48
267 CARDIAC FAILURE CONGESTIVE 47
268 HEREDITARY ANGIOEDEMA 47
269 HYPOGLYCAEMIA 47
270 LETHARGY 47
271 PANCREATITIS 47
272 SEDATION 47
273 SLEEP APNOEA SYNDROME 47
274 BRADYCARDIA 46
275 BRAIN FOG 46
276 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46
277 END STAGE RENAL DISEASE 46
278 FLATULENCE 46
279 LIMB DISCOMFORT 46
280 MATERNAL EXPOSURE DURING PREGNANCY 46
281 PLEURAL EFFUSION 46
282 ACNE 45
283 DEPRESSED LEVEL OF CONSCIOUSNESS 45
284 FEBRILE NEUTROPENIA 45
285 GAIT INABILITY 45
286 HEPATIC ENZYME INCREASED 45
287 LIMB INJURY 45
288 POISONING DELIBERATE 45
289 SKIN ULCER 45
290 BLOOD POTASSIUM DECREASED 44
291 INFUSION SITE PRURITUS 44
292 PULMONARY OEDEMA 44
293 SPEECH DISORDER 44
294 HYPERGLYCAEMIA 43
295 HYPERKALAEMIA 43
296 INFLAMMATION 43
297 LIP SWELLING 43
298 NIGHT SWEATS 43
299 PHOTOPHOBIA 43
300 POLLAKIURIA 43
301 WHITE BLOOD CELL COUNT INCREASED 43
302 CONJUNCTIVITIS 42
303 HEAD INJURY 42
304 INFUSION SITE SWELLING 42
305 POOR QUALITY SLEEP 42
306 PULMONARY EMBOLISM 42
307 BLOOD CHOLESTEROL INCREASED 41
308 CRYING 41
309 DELIRIUM 41
310 DEVICE ISSUE 41
311 INTESTINAL OBSTRUCTION 41
312 IRRITABLE BOWEL SYNDROME 41
313 LYMPHADENOPATHY 41
314 SKIN DISORDER 41
315 SKIN INFECTION 41
316 TYPE 2 DIABETES MELLITUS 41
317 ADVERSE EVENT 40
318 FEELING COLD 40
319 GASTROENTERITIS VIRAL 40
320 SKIN SWELLING 40
321 ACCIDENTAL OVERDOSE 39
322 AGGRESSION 39
323 DRUG EFFECT LESS THAN EXPECTED 39
324 DYSARTHRIA 39
325 KIDNEY INFECTION 39
326 NEOPLASM MALIGNANT 39
327 NERVOUSNESS 39
328 POISONING 39
329 RIB FRACTURE 39
330 CANDIDA INFECTION 38
331 EAR PAIN 38
332 HERNIA 38
333 NEURALGIA 38
334 DIABETES MELLITUS INADEQUATE CONTROL 37
335 IMPAIRED GASTRIC EMPTYING 37
336 INITIAL INSOMNIA 37
337 IRRITABILITY 37
338 LIVER DISORDER 37
339 NEUTROPHIL COUNT DECREASED 37
340 OSTEOPENIA 37
341 RED BLOOD CELL COUNT DECREASED 37
342 RENAL DISORDER 37
343 UNDERDOSE 37
344 BLOOD CREATININE INCREASED 36
345 OSTEOARTHRITIS 36
346 PAIN OF SKIN 36
347 PNEUMONIA ASPIRATION 36
348 SINUS DISORDER 36
349 CORONARY ARTERY DISEASE 35
350 DEMENTIA 35
351 DEVICE DISLOCATION 35
352 FIBROMYALGIA 35
353 INJECTION SITE HAEMORRHAGE 35
354 PULMONARY HYPERTENSION 35
355 RHABDOMYOLYSIS 35
356 VASCULAR DEVICE INFECTION 35
357 NEURODERMATITIS 34
358 THERAPY PARTIAL RESPONDER 34
359 TREATMENT FAILURE 34
360 UPPER LIMB FRACTURE 34
361 VITAMIN D DEFICIENCY 34
362 ALTERED STATE OF CONSCIOUSNESS 33
363 BACTERIAL INFECTION 33
364 DISEASE PROGRESSION 33
365 GASTROINTESTINAL HAEMORRHAGE 33
366 INTERVERTEBRAL DISC PROTRUSION 33
367 MELAENA 33
368 MIDDLE INSOMNIA 33
369 OCULAR DISCOMFORT 33
370 PHARYNGEAL SWELLING 33
371 PRODUCT DISPENSING ERROR 33
372 RESPIRATORY TRACT CONGESTION 33
373 DISORIENTATION 32
374 MENTAL STATUS CHANGES 32
375 PHARYNGITIS STREPTOCOCCAL 32
376 PROCEDURAL PAIN 32
377 SNEEZING 32
378 THROAT TIGHTNESS 32
379 BLOOD PRESSURE ABNORMAL 31
380 BLOOD UREA INCREASED 31
381 DIPLOPIA 31
382 ECONOMIC PROBLEM 31
383 EYE DISORDER 31
384 FEMUR FRACTURE 31
385 FOOT FRACTURE 31
386 HEART RATE DECREASED 31
387 HYPOTHYROIDISM 31
388 INJECTION SITE MASS 31
389 INJECTION SITE RASH 31
390 JOINT STIFFNESS 31
391 LOWER LIMB FRACTURE 31
392 MULTIPLE SCLEROSIS RELAPSE 31
393 MUSCULOSKELETAL CHEST PAIN 31
394 NIGHTMARE 31
395 PANCYTOPENIA 31
396 POST PROCEDURAL COMPLICATION 31
397 SKIN LESION 31
398 THIRST 31
399 TOOTH INFECTION 31
400 TRANSIENT ISCHAEMIC ATTACK 31
401 ENCEPHALOPATHY 30
402 EXTRA DOSE ADMINISTERED 30
403 EYE INFECTION 30
404 GASTRITIS 30
405 HAEMATOCHEZIA 30
406 HIATUS HERNIA 30
407 INJURY 30
408 PRESYNCOPE 30
409 RASH PAPULAR 30
410 RESTLESS LEGS SYNDROME 30
411 SKIN PLAQUE 30
412 THERAPEUTIC PRODUCT EFFECT DECREASED 30
413 TOXIC EPIDERMAL NECROLYSIS 30
414 ACUTE RESPIRATORY FAILURE 29
415 ASCITES 29
416 DEVICE INFUSION ISSUE 29
417 OBESITY 29
418 RETCHING 29
419 SPUTUM DISCOLOURED 29
420 WRIST FRACTURE 29
421 BLOOD SODIUM DECREASED 28
422 DEVICE MALFUNCTION 28
423 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28
424 HAEMOGLOBIN INCREASED 28
425 HYPOPHAGIA 28
426 METABOLIC ACIDOSIS 28
427 MIOSIS 28
428 POOR VENOUS ACCESS 28
429 PRE-EXISTING CONDITION IMPROVED 28
430 PRODUCT DISTRIBUTION ISSUE 28
431 PSYCHOTIC DISORDER 28
432 RENAL INJURY 28
433 RESPIRATORY ARREST 28
434 RESPIRATORY SYNCYTIAL VIRUS INFECTION 28
435 THERAPEUTIC RESPONSE UNEXPECTED 28
436 TOOTH ABSCESS 28
437 URINARY INCONTINENCE 28
438 ANGINA PECTORIS 27
439 BLINDNESS 27
440 COLITIS 27
441 COMPLICATION ASSOCIATED WITH DEVICE 27
442 JOINT INJURY 27
443 ORAL CANDIDIASIS 27
444 PRODUCT AVAILABILITY ISSUE 27
445 WEIGHT FLUCTUATION 27
446 BACK DISORDER 26
447 BLOOD GLUCOSE DECREASED 26
448 BLOOD PRESSURE FLUCTUATION 26
449 DERMATITIS ALLERGIC 26
450 DIVERTICULITIS 26
451 EXPOSURE DURING PREGNANCY 26
452 FEEDING DISORDER 26
453 HEPATIC FUNCTION ABNORMAL 26
454 HYPOACUSIS 26
455 LABORATORY TEST ABNORMAL 26
456 LEUKOCYTOSIS 26
457 MULTIPLE SCLEROSIS 26
458 SEPTIC SHOCK 26
459 SYSTEMIC LUPUS ERYTHEMATOSUS 26
460 VICTIM OF CRIME 26
461 WITHDRAWAL SYNDROME 26
462 WOUND 26
463 CLOSTRIDIUM DIFFICILE INFECTION 25
464 DRUG WITHDRAWAL SYNDROME 25
465 HYPOALBUMINAEMIA 25
466 NEPHROGENIC ANAEMIA 25
467 NERVOUS SYSTEM DISORDER 25
468 ORTHOSTATIC HYPOTENSION 25
469 PERICARDIAL EFFUSION 25
470 PERIORBITAL SWELLING 25
471 PRODUCT QUALITY ISSUE 25
472 SCIATICA 25
473 SKIN LACERATION 25
474 ARRHYTHMIA 24
475 ARTHROPATHY 24
476 CHOLESTASIS 24
477 DRUG DOSE OMISSION 24
478 DYSGEUSIA 24
479 EMOTIONAL DISORDER 24
480 FOETAL EXPOSURE DURING PREGNANCY 24
481 HEPATIC STEATOSIS 24
482 HYPERVOLAEMIA 24
483 INFUSION SITE INFECTION 24
484 INJECTION SITE URTICARIA 24
485 MASS 24
486 MUSCLE TWITCHING 24
487 PHOTOSENSITIVITY REACTION 24
488 PRODUCT STORAGE ERROR 24
489 RESPIRATORY DISTRESS 24
490 SINUS CONGESTION 24
491 SKIN DISCOMFORT 24
492 TOOTH DISORDER 24
493 UNRESPONSIVE TO STIMULI 24
494 ANKLE FRACTURE 23
495 CARPAL TUNNEL SYNDROME 23
496 CHOLECYSTECTOMY 23
497 DYSSTASIA 23
498 EATING DISORDER 23
499 INCORRECT PRODUCT ADMINISTRATION DURATION 23
500 INTENTIONAL SELF-INJURY 23
501 MULTIPLE ORGAN DYSFUNCTION SYNDROME 23
502 MUSCLE RIGIDITY 23
503 NEEDLE ISSUE 23
504 PANCREATITIS ACUTE 23
505 RESPIRATORY DEPRESSION 23
506 RESPIRATORY DISORDER 23
507 SPINAL FRACTURE 23
508 STEVENS-JOHNSON SYNDROME 23
509 ULCER 23
510 ABNORMAL DREAMS 22
511 BLOOD BILIRUBIN INCREASED 22
512 BLOOD URINE PRESENT 22
513 DENTAL CARIES 22
514 DISEASE RECURRENCE 22
515 EAR DISCOMFORT 22
516 FAECES DISCOLOURED 22
517 HALLUCINATION, VISUAL 22
518 INFUSION SITE EXTRAVASATION 22
519 KNEE ARTHROPLASTY 22
520 POST-TRAUMATIC STRESS DISORDER 22
521 PRIAPISM 22
522 PRODUCT ADMINISTRATION ERROR 22
523 RESTLESSNESS 22
524 TASTE DISORDER 22
525 TENDERNESS 22
526 UPPER-AIRWAY COUGH SYNDROME 22
527 AGRANULOCYTOSIS 21
528 ANAPHYLACTIC SHOCK 21
529 ATRIOVENTRICULAR BLOCK FIRST DEGREE 21
530 BLOOD ALKALINE PHOSPHATASE INCREASED 21
531 BLOOD IRON DECREASED 21
532 BONE DENSITY DECREASED 21
533 BREAST CANCER 21
534 DEVICE BREAKAGE 21
535 DYSKINESIA 21
536 ORAL PAIN 21
537 PARKINSONISM 21
538 PRODUCT USE COMPLAINT 21
539 ROTATOR CUFF SYNDROME 21
540 SCAR 21
541 SPINAL OPERATION 21
542 SWOLLEN TONGUE 21
543 TOOTHACHE 21
544 ABNORMAL BEHAVIOUR 20
545 ASPHYXIA 20
546 CARDIOGENIC SHOCK 20
547 COLD SWEAT 20
548 CONTRAINDICATED PRODUCT ADMINISTERED 20
549 DISABILITY 20
550 EYE DISCHARGE 20
551 FACIAL PAIN 20
552 FOOD ALLERGY 20
553 GASTRIC ULCER 20
554 GOUT 20
555 HAEMORRHOIDS 20
556 HIP FRACTURE 20
557 INFUSION SITE BRUISING 20
558 JAUNDICE 20
559 LIGAMENT SPRAIN 20
560 MAJOR DEPRESSION 20
561 MOTOR DYSFUNCTION 20
562 QUALITY OF LIFE DECREASED 20
563 RECTAL HAEMORRHAGE 20
564 RENAL FAILURE ACUTE 20
565 RESPIRATORY ACIDOSIS 20
566 SCAB 20
567 SENSITIVE SKIN 20
568 SKIN WEEPING 20
569 ACUTE RESPIRATORY DISTRESS SYNDROME 19
570 ANGER 19
571 BLOOD POTASSIUM INCREASED 19
572 BRADYKINESIA 19
573 CHOLELITHIASIS 19
574 COVID-19 PNEUMONIA 19
575 CROHN^S DISEASE 19
576 DECREASED ACTIVITY 19
577 DEVICE DIFFICULT TO USE 19
578 DEVICE LEAKAGE 19
579 FEELING DRUNK 19
580 FULL BLOOD COUNT ABNORMAL 19
581 GALLBLADDER DISORDER 19
582 HALLUCINATION, AUDITORY 19
583 HUNGER 19
584 IMPAIRED HEALING 19
585 INTERSTITIAL LUNG DISEASE 19
586 LIVER FUNCTION TEST ABNORMAL 19
587 MALIGNANT NEOPLASM PROGRESSION 19
588 MAST CELL ACTIVATION SYNDROME 19
589 MENTAL IMPAIRMENT 19
590 MYDRIASIS 19
591 OVARIAN CYST 19
592 PHARYNGITIS 19
593 PNEUMOTHORAX 19
594 SWELLING OF EYELID 19
595 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 19
596 AFFECTIVE DISORDER 18
597 ANGINA UNSTABLE 18
598 APHASIA 18
599 APHONIA 18
600 ARTERIOSCLEROSIS 18
601 BIPOLAR DISORDER 18
602 C-REACTIVE PROTEIN INCREASED 18
603 CONCUSSION 18
604 DYSTONIA 18
605 EYELID PAIN 18
606 FACE OEDEMA 18
607 GASTRIC POLYPS 18
608 HYSTERECTOMY 18
609 INCREASED APPETITE 18
610 LARYNGITIS 18
611 LIVER FUNCTION TEST INCREASED 18
612 LUNG NEOPLASM MALIGNANT 18
613 MOOD ALTERED 18
614 MOUTH ULCERATION 18
615 MULTIPLE DRUG THERAPY 18
616 MUSCULOSKELETAL DISCOMFORT 18
617 NEOPLASM PROGRESSION 18
618 PALLOR 18
619 PLATELET COUNT INCREASED 18
620 PRODUCT PREPARATION ERROR 18
621 PRODUCT PRESCRIBING ERROR 18
622 TUBULOINTERSTITIAL NEPHRITIS 18
623 AUTOIMMUNE THYROIDITIS 17
624 BACTERAEMIA 17
625 CONVULSION 17
626 DISTRIBUTIVE SHOCK 17
627 GASTRIC DISORDER 17
628 GASTROENTERITIS 17
629 GLAUCOMA 17
630 HAEMATEMESIS 17
631 HAND FRACTURE 17
632 HEPATIC FAILURE 17
633 HIP ARTHROPLASTY 17
634 HYPOTONIA 17
635 INABILITY TO AFFORD MEDICATION 17
636 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 17
637 MALNUTRITION 17
638 MOVEMENT DISORDER 17
639 MUSCULOSKELETAL PAIN 17
640 NERVE COMPRESSION 17
641 NEUROBLASTOMA RECURRENT 17
642 ORAL DISCOMFORT 17
643 OSTEOMYELITIS 17
644 PEPTIC ULCER 17
645 PRODUCT PRESCRIBING ISSUE 17
646 PULMONARY ARTERIAL HYPERTENSION 17
647 SECRETION DISCHARGE 17
648 THERAPY CESSATION 17
649 VENTRICULAR TACHYCARDIA 17
650 WRONG PRODUCT ADMINISTERED 17
651 ACCIDENT 16
652 ACUTE MYOCARDIAL INFARCTION 16
653 AGEUSIA 16
654 ATTENTION DEFICIT HYPERACTIVITY DISORDER 16
655 CHROMATURIA 16
656 CYANOSIS 16
657 DEVICE RELATED INFECTION 16
658 DRUG ERUPTION 16
659 EPILEPSY 16
660 FEELING OF DESPAIR 16
661 FULL BLOOD COUNT DECREASED 16
662 GASTROINTESTINAL INFECTION 16
663 GENERALISED TONIC-CLONIC SEIZURE 16
664 HEAD DISCOMFORT 16
665 HEAVY MENSTRUAL BLEEDING 16
666 HEPATIC CIRRHOSIS 16
667 IMMUNODEFICIENCY 16
668 INCORRECT DRUG ADMINISTRATION RATE 16
669 INFUSION SITE REACTION 16
670 INJECTION SITE DISCOMFORT 16
671 MICTURITION DISORDER 16
672 OBSTRUCTIVE AIRWAYS DISORDER 16
673 OROPHARYNGEAL DISCOMFORT 16
674 PRODUCT NAME CONFUSION 16
675 PULMONARY MASS 16
676 SARS-COV-2 TEST POSITIVE 16
677 SINUS TACHYCARDIA 16
678 SKIN ABRASION 16
679 SNORING 16
680 SPINAL CORD COMPRESSION 16
681 STUPOR 16
682 TEMPERATURE INTOLERANCE 16
683 TOOTH FRACTURE 16
684 BACTERIAL DISEASE CARRIER 15
685 BLOOD CREATINE INCREASED 15
686 BLOOD TRIGLYCERIDES INCREASED 15
687 BODY TEMPERATURE INCREASED 15
688 CARDIOMEGALY 15
689 DEAFNESS 15
690 DIZZINESS POSTURAL 15
691 FEELING JITTERY 15
692 HAEMOPTYSIS 15
693 HEART RATE IRREGULAR 15
694 HYPERLIPIDAEMIA 15
695 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15
696 INFUSION SITE INDURATION 15
697 INFUSION SITE WARMTH 15
698 INJECTION SITE DISCOLOURATION 15
699 LEUKOPENIA 15
700 MOOD SWINGS 15
701 PEMPHIGOID 15
702 PERICARDITIS 15
703 PERIPHERAL CIRCULATORY FAILURE 15
704 PETECHIAE 15
705 PRODUCT DOSE OMISSION 15
706 SENSORY DISTURBANCE 15
707 SOMNAMBULISM 15
708 TOOTH LOSS 15
709 UNINTENTIONAL MEDICAL DEVICE REMOVAL 15
710 VASCULITIS 15
711 ARTHROPOD BITE 14
712 BACK INJURY 14
713 BLOOD CREATINE PHOSPHOKINASE INCREASED 14
714 BLOOD PRESSURE SYSTOLIC INCREASED 14
715 DERMATITIS EXFOLIATIVE GENERALISED 14
716 DEVICE MAINTENANCE ISSUE 14
717 DISSEMINATED INTRAVASCULAR COAGULATION 14
718 EAR DISORDER 14
719 EYELIDS PRURITUS 14
720 HYPERTHERMIA 14
721 HYPOKINESIA 14
722 ILEUS 14
723 IMMUNE SYSTEM DISORDER 14
724 INCREASED TENDENCY TO BRUISE 14
725 INTERVERTEBRAL DISC DEGENERATION 14
726 LEUKAEMIA 14
727 MIXED LIVER INJURY 14
728 MULTIPLE FRACTURES 14
729 MUSCLE TIGHTNESS 14
730 OSTEONECROSIS 14
731 POST PROCEDURAL INFECTION 14
732 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14
733 RALES 14
734 RASH PUSTULAR 14
735 RENAL TUBULAR NECROSIS 14
736 SHOCK 14
737 SKIN MASS 14
738 SPLENOMEGALY 14
739 TARDIVE DYSKINESIA 14
740 TOOTH EXTRACTION 14
741 VASCULAR ACCESS SITE COMPLICATION 14
742 VENTRICULAR FIBRILLATION 14
743 VICTIM OF CHEMICAL SUBMISSION 14
744 VITREOUS FLOATERS 14
745 ABORTION SPONTANEOUS 13
746 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 13
747 ANAL INCONTINENCE 13
748 AUTISM SPECTRUM DISORDER 13
749 BLOOD DISORDER 13
750 BRONCHIAL SECRETION RETENTION 13
751 BRONCHIAL WALL THICKENING 13
752 CHOKING 13
753 COLITIS ULCERATIVE 13
754 DEVICE USE ISSUE 13
755 DISSOCIATION 13
756 DRUG USE DISORDER 13
757 DRY THROAT 13
758 ELECTROLYTE IMBALANCE 13
759 EOSINOPHIL COUNT INCREASED 13
760 EOSINOPHILIC OESOPHAGITIS 13
761 EYE INFLAMMATION 13
762 FEAR 13
763 FOOT OPERATION 13
764 HYPERPARATHYROIDISM SECONDARY 13
765 INFUSION SITE IRRITATION 13
766 LOWER RESPIRATORY TRACT INFECTION 13
767 NEUROGLYCOPENIA 13
768 OBSTRUCTIVE SLEEP APNOEA SYNDROME 13
769 PAPULE 13
770 PARANOIA 13
771 PNEUMONIA BACTERIAL 13
772 PNEUMONITIS 13
773 POSTOPERATIVE WOUND INFECTION 13
774 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 13
775 PRODUCT SUBSTITUTION ISSUE 13
776 PSYCHOMOTOR HYPERACTIVITY 13
777 REBOUND ATOPIC DERMATITIS 13
778 REBOUND EFFECT 13
779 RENAL PAIN 13
780 RHINITIS ALLERGIC 13
781 STAPHYLOCOCCAL BACTERAEMIA 13
782 STREPTOCOCCAL INFECTION 13
783 SYMPTOM RECURRENCE 13
784 THERMAL BURN 13
785 THINKING ABNORMAL 13
786 THYROID DISORDER 13
787 TOXIC SKIN ERUPTION 13
788 TRISMUS 13
789 VITAMIN D DECREASED 13
790 ABSCESS 12
791 ANOSMIA 12
792 ANTICHOLINERGIC SYNDROME 12
793 AUTOIMMUNE DISORDER 12
794 BLOOD CHOLESTEROL DECREASED 12
795 BONE MARROW FAILURE 12
796 CHEMICAL SUBMISSION 12
797 COELIAC DISEASE 12
798 DEVICE FAILURE 12
799 EMPHYSEMA 12
800 ENURESIS 12
801 EXERCISE TOLERANCE DECREASED 12
802 EXPIRED PRODUCT ADMINISTERED 12
803 FLANK PAIN 12
804 FOREIGN BODY SENSATION IN EYES 12
805 GLYCOSYLATED HAEMOGLOBIN INCREASED 12
806 GRAFT VERSUS HOST DISEASE 12
807 GRAFT VERSUS HOST DISEASE IN SKIN 12
808 GROIN PAIN 12
809 HEPATOCELLULAR INJURY 12
810 HYPERBILIRUBINAEMIA 12
811 HYPOPHOSPHATAEMIA 12
812 HYPOTHERMIA 12
813 IMPAIRED WORK ABILITY 12
814 INFUSION SITE MASS 12
815 MANIA 12
816 MUSCLE SPASTICITY 12
817 NEOPLASM 12
818 NERVE INJURY 12
819 NEUTROPHIL COUNT INCREASED 12
820 NOCTURIA 12
821 OBSTRUCTION 12
822 PARKINSON^S DISEASE 12
823 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12
824 POTENTIATING DRUG INTERACTION 12
825 PRESCRIBED OVERDOSE 12
826 PRODUCT ADHESION ISSUE 12
827 PURULENT DISCHARGE 12
828 RESPIRATION ABNORMAL 12
829 RHINITIS 12
830 SJOGREN^S SYNDROME 12
831 SKIN ATROPHY 12
832 SLEEP TERROR 12
833 SLUGGISHNESS 12
834 SPINAL OSTEOARTHRITIS 12
835 TENDONITIS 12
836 VISUAL ACUITY REDUCED 12
837 APATHY 11
838 APHTHOUS ULCER 11
839 ATYPICAL PNEUMONIA 11
840 AUTONOMIC NERVOUS SYSTEM IMBALANCE 11
841 BLOOD LACTATE DEHYDROGENASE INCREASED 11
842 BLOOD TEST ABNORMAL 11
843 BRONCHOSPASM 11
844 BRUXISM 11
845 CLOSTRIDIUM DIFFICILE COLITIS 11
846 CYST 11
847 DECREASED IMMUNE RESPONSIVENESS 11
848 DERMATITIS BULLOUS 11
849 DRUG LEVEL INCREASED 11
850 ELECTRIC SHOCK SENSATION 11
851 ERYTHEMA OF EYELID 11
852 ESCHERICHIA INFECTION 11
853 FACIAL PARALYSIS 11
854 FEAR OF INJECTION 11
855 FURUNCLE 11
856 GENERALISED OEDEMA 11
857 GINGIVAL BLEEDING 11
858 GINGIVITIS 11
859 GLOSSODYNIA 11
860 HAEMATOCRIT DECREASED 11
861 HAEMATOCRIT INCREASED 11
862 HALLUCINATIONS, MIXED 11
863 HORDEOLUM 11
864 HOSPICE CARE 11
865 HYPERVENTILATION 11
866 HYPOGAMMAGLOBULINAEMIA 11
867 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11
868 INJECTION SITE DISCHARGE 11
869 INJECTION SITE INDURATION 11
870 INJECTION SITE IRRITATION 11
871 LABELLED DRUG-DRUG INTERACTION ISSUE 11
872 MICTURITION URGENCY 11
873 ORAL DISORDER 11
874 PARANASAL SINUS DISCOMFORT 11
875 PRESCRIBED UNDERDOSE 11
876 PRODUCT PREPARATION ISSUE 11
877 PULMONARY CONGESTION 11
878 PURPURA 11
879 SENSITIVITY TO WEATHER CHANGE 11
880 SKIN CANCER 11
881 SUBDURAL HAEMATOMA 11
882 TRANSCRIPTION MEDICATION ERROR 11
883 VEIN DISORDER 11
884 WALKING AID USER 11
885 WOUND INFECTION 11
886 ABDOMINAL PAIN LOWER 10
887 ACIDOSIS 10
888 ASPIRATION 10
889 BLOOD PRESSURE SYSTOLIC DECREASED 10
890 BONE DISORDER 10
891 BOWEL MOVEMENT IRREGULARITY 10
892 BRAIN OEDEMA 10
893 BRONCHOPULMONARY ASPERGILLOSIS 10
894 CATHETER SITE HAEMORRHAGE 10
895 CEREBRAL DISORDER 10
896 CHOLECYSTITIS 10
897 CHRONIC SPONTANEOUS URTICARIA 10
898 DECUBITUS ULCER 10
899 DELUSION 10
900 DEVICE USE ERROR 10
901 DROWNING 10
902 DRUG DIVERSION 10
903 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
904 EYELID PTOSIS 10
905 FUNGAL SKIN INFECTION 10
906 GASTROINTESTINAL INFLAMMATION 10
907 HAEMATURIA 10
908 HERPES SIMPLEX 10
909 HYPOCALCAEMIA 10
910 HYPOMAGNESAEMIA 10
911 IMMUNOSUPPRESSION 10
912 KNEE OPERATION 10
913 LABYRINTHITIS 10
914 LIP DRY 10
915 MENINGITIS ASEPTIC 10
916 MOUTH SWELLING 10
917 PELVIC PAIN 10
918 PERIORBITAL PAIN 10
919 PIGMENTARY MACULOPATHY 10
920 PRODUCT LEAKAGE 10
921 PULMONARY THROMBOSIS 10
922 ROSACEA 10
923 SCOLIOSIS 10
924 SERUM FERRITIN DECREASED 10
925 SPINAL DISORDER 10
926 SUPRAVENTRICULAR TACHYCARDIA 10
927 SYRINGE ISSUE 10
928 TACHYPNOEA 10
929 TENSION HEADACHE 10
930 TORSADE DE POINTES 10
931 URINE OUTPUT DECREASED 10
932 VAGINAL INFECTION 10
933 VENTRICULAR EXTRASYSTOLES 10
934 ABASIA 9
935 ABDOMINAL MASS 9
936 BASAL CELL CARCINOMA 9
937 BEDRIDDEN 9
938 BLOOD ALBUMIN DECREASED 9
939 BLOOD LACTIC ACID INCREASED 9
940 BRADYPNOEA 9
941 CARDIAC MURMUR 9
942 CATHETER SITE ERYTHEMA 9
943 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 9
944 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9
945 COAGULOPATHY 9
946 DEVICE DEFECTIVE 9
947 DEVICE PHYSICAL PROPERTY ISSUE 9
948 DYSMENORRHOEA 9
949 EAR SWELLING 9
950 ENDOCRINE OPHTHALMOPATHY 9
951 ERECTILE DYSFUNCTION 9
952 ESSENTIAL HYPERTENSION 9
953 EXOSTOSIS 9
954 EYE HAEMORRHAGE 9
955 FOLLICULITIS 9
956 FRUSTRATION TOLERANCE DECREASED 9
957 GINGIVAL PAIN 9
958 HAIR GROWTH ABNORMAL 9
959 HEPATIC ENCEPHALOPATHY 9
960 HEPATOTOXICITY 9
961 HIDRADENITIS 9
962 HOMICIDAL IDEATION 9
963 HUMERUS FRACTURE 9
964 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 9
965 INFUSION SITE DISCOMFORT 9
966 INFUSION SITE URTICARIA 9
967 IRON DEFICIENCY 9
968 IRON DEFICIENCY ANAEMIA 9
969 LACTIC ACIDOSIS 9
970 MENISCUS INJURY 9
971 METASTASES TO LUNG 9
972 MITRAL VALVE INCOMPETENCE 9
973 NAIL DISORDER 9
974 NEPHROPATHY 9
975 OBSESSIVE-COMPULSIVE DISORDER 9
976 OESOPHAGEAL CANDIDIASIS 9
977 PARALYSIS 9
978 PNEUMONIA FUNGAL 9
979 POLYNEUROPATHY 9
980 PROCEDURAL COMPLICATION 9
981 PRURITUS GENERALISED 9
982 PRURITUS GENITAL 9
983 REBOUND ACID HYPERSECRETION 9
984 REGURGITATION 9
985 RETINAL PIGMENTATION 9
986 RHINOVIRUS INFECTION 9
987 SKIN WRINKLING 9
988 SLEEP-RELATED EATING DISORDER 9
989 SPINAL COMPRESSION FRACTURE 9
990 SPINAL PAIN 9
991 TRICUSPID VALVE INCOMPETENCE 9
992 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 8
993 ADVERSE REACTION 8
994 AORTIC VALVE INCOMPETENCE 8
995 APNOEA 8
996 ASTHENOPIA 8
997 ATRIAL TACHYCARDIA 8
998 BEHAVIOUR DISORDER 8
999 BLADDER DISORDER 8